Cancer Biotech Co. Bellicum Pharma Files For $115M IPO
Cancer-focused drug company Bellicum Pharmaceuticals Inc. filed for a $115 million initial public offering Tuesday, seeking capital to develop innovative medicines that fight disease by harnessing the body's immune system, joining...To view the full article, register now.
Already a subscriber? Click here to view full article